REGENERON PHARMACEUTICALS, INC.

Q4 2025 13F Holdings

Location
tarrytown, NY
Num holdings

2
Value ($000)

$33,799
Date Filed

02/06/2026
Form type

13F-HR
CIK

0000872589
All SEC filings
View on sec.gov
Note
Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers

Compare Q4 2025 to

Select Quarter

Issuer Name	Class	CUSIP	VALUE	%	Shares	Principal	Option Type
N NTLA Intellia Therapeutics, Inc.	COMMON STOCK	45826J105	$33.29M	99 %	3,702,995
A ACET Adicet Bio, Inc.	COMMON STOCK	007002108	$509.5K	2 %	60,511

Rows Per Page

1 - 2 of 2